1Y Annualised Return
▼-28.82%
3Y Annualised Return
▲17.12%
5Y Annualised Return
▲14.61%
Aspira Pathlab & Diagnostics Stock Performance
|
|
|
Aspira Pathlab & Diagnostics Company background
Founded in: 1973
Managing director: Pankaj Jashwant Shah
Aspira Pathlab Diagnostics Limited (ASDL) was incorporated in July, 1973. ASDL is a leading pathology specialist, with PanIndia presence. It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses. The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services.Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.ASDL ideology is founded on technological supremacy, patient centric approach, and dependable diagnostic results. During the year 2016, the Company commenced its business activities of diagnostic center pathology from November 2016 onwards by acquiring running business activities of Ankur Pathology Laboratory. Aspira is focused on establishing itself as a strong regional player before scaling up its operations. Although, it follow an asset light model, other costs are significantly high. Most of these cost is front ended and the payback period is high. It is therefore working on building the right systems and optimize the cost. It is adopting new technologies that improve customer experience. Some of these are use of Chatbot, improving website, implementing patient engagement platform, Customer Service, etc. Also concentrating more on HLM, trying to expand area by targeting newly setup hospitals and laboratory and trying to achieve more technology and advancement.Company floated an associate LLP i.e Aspira DNA Diagnostics Gujarat LLP on April 2, 2024.
Aspira Pathlab & Diagnostics Financial Highlights
For the full year FY2025–2026, revenue
reached ₹22.39 crore and profit touched at
₹2.07 crore.
Aspira Pathlab & Diagnostics Share Price Today
As of 7 Mar 2026, Aspira Pathlab & Diagnostics share price is ₹62.6. The stock opened at ₹56.6 and had closed at ₹56 the previous day. During today’s trading session, Aspira Pathlab & Diagnostics share price moved between ₹51.90 and ₹63.35, with an average price for the day of ₹57.63. Over the last 52 weeks, the stock has recorded a low of ₹50.49 and a high of ₹106.78. In terms of performance, Aspira Pathlab & Diagnostics share price has declined by 2.2% over the past six months and has declined by 28.82% over the last year.
Aspira Pathlab & Diagnostics SIP Return Calculator
₹5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of ₹5,000 would have become ₹4,43,519 in 5 years with a gain of ₹1,43,519 (+47.84%)

View details of Market Depth
Aspira Pathlab & Diagnostics Fundamental
Market Cap (in crs)
64.41
Face Value
10
Turnover (in lacs)
0.48
Key Metrics
Qtr Change %
41.39% Fall from 52W High
-7.5
Dividend yield 1yr %
0
Aspira Pathlab & Diagnostics Key Financials
View moreLoading chart...
Aspira Pathlab & Diagnostics Quarterly Revenue
5.25 Cr | 5.78 Cr | 5.41 Cr | 6.18 Cr | 4.64 Cr |
Aspira Pathlab & Diagnostics Yearly Revenue
22.39 Cr | 13.63 Cr |
Aspira Pathlab & Diagnostics Quarterly Net Profit/Loss
0.47 Cr | 0.72 Cr | 0.31 Cr | 0.99 Cr | -0.02 Cr |
Aspira Pathlab & Diagnostics Yearly Net Profit/Loss
2.07 Cr | -2.67 Cr |
Aspira Pathlab & Diagnostics Technical Analysis
Moving Averages Analysis
62.58
Current Price
Bullish Moving Averages
11
Bearish Moving Averages
5
Day EMA5
59.00
Day EMA10
59.20
Day EMA12
59.40
Day EMA20
60.30
Day EMA26
60.80
Day EMA50
62.10
Day EMA100
63.00
Day EMA200
62.60
Delivery & Volume
Loading chart...
Delivery Volume %
Day
62.80%
Week
65.90%
Month
72.40%
Delivery & Volume
Day Rs | 486 Rs | 774 Rs |
Week Rs | 196 Rs | 298 Rs |
Month Rs | 906 Rs | 1252 Rs |
Resistance & Support
59.28
Pivot
Resistance
First Resistance
66.65
Second Resistance
70.73
Third Resistance
78.10
Support
First Support
55.20
Second support
47.83
Third Support
43.75
Relative Strength Index
53.29
Money Flow Index
63.17
MACD
-1.44
MACD Signal
-1.40
Average True Range
3.81
Average Directional Index
23.13
Rate of Change (21)
-3.71
Rate of Change (125)
-2.22
Aspira Pathlab & Diagnostics Peer comparison
Compare31.10 +0.11 (+0.35%)▲ | |
96.05 +6.40 (+7.14%)▲ | |
143.45 +4.90 (+3.54%)▲ | |
17.88 +0.29 (+1.65%)▲ | |
93.00 +0.98 (+1.06%)▲ | |
65.45 -5.40 (-7.62%)▼ |
Aspira Pathlab & Diagnostics Latest News
View More
Aspira Pathlab & Diagnostics Share Price FAQs
Please be aware that Aspira Pathlab & Diagnostics stock prices are subject to continuous fluctuations due to various factors.